Faculty Opinions recommendation of Randomized phase II trial of ridaforolimus in advanced endometrial carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725563727.793527269 ◽

2017 ◽

Author(s):

Paola Gehrig

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text

1400: A Randomized Phase II Trial Evaluating the Importance of Early Erectile Dysfunction Rehabilitation and Unilateral Autologous Sural Nerve Grafting in Patients Undergoing a Unilateral Cavernous Nerve Sparing Radical Prostatectomy for Clinically localized PR

The Journal of Urology ◽

10.1016/s0022-5347(18)31601-x ◽

2007 ◽

Vol 177 (4S) ◽

pp. 461-461 ◽

Author(s):

Christopher G. Wood ◽

David Chang ◽

Run Wang ◽

Yu Shen ◽

Curtis A. Pettaway ◽

...

Keyword(s):

Erectile Dysfunction ◽

Radical Prostatectomy ◽

Phase Ii ◽

Sural Nerve ◽

Phase Ii Trial ◽

Nerve Sparing ◽

Nerve Grafting ◽

Cavernous Nerve ◽

Randomized Phase Ii

Download Full-text

RANDOMIZED PHASE II TRIAL OF CARBOPLATIN-PACLITAXEL COMPARED TO CARBOPLATIN-PACLITAXEL-TRASTUZUMAB IN ADVANCED (STAGE III-IV) OR RECURRENT UTERINE SEROUS CARCINOMA: RESULTS OF INTERIM ANALYSIS (NCT01367002)

10.26226/morressier.5770e29bd462b80290b4bae3 ◽

2016 ◽

Author(s):

Alessandro D Santin

Keyword(s):

Phase Ii ◽

Interim Analysis ◽

Phase Ii Trial ◽

Stage Iii ◽

Serous Carcinoma ◽

Advanced Stage ◽

Randomized Phase Ii ◽

Uterine Serous Carcinoma

Download Full-text

Faculty Opinions recommendation of A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697918.793457734 ◽

2012 ◽

Author(s):

Hans-Joachim Schmoll

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Faculty of 1000 evaluation for Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717969496.793472190 ◽

2013 ◽

Author(s):

Andreas Hoeft

Keyword(s):

Critically Ill ◽

Phase Ii ◽

Critically Ill Patients ◽

Phase Ii Trial ◽

Deep Sedation ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969752.793471344 ◽

2013 ◽

Author(s):

David Kushner ◽

Ryan Spencer

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

Faculty Opinions recommendation of PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718144304.793486590 ◽

2013 ◽

Author(s):

Roberto Angioli

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Pegylated Liposomal Doxorubicin ◽

Platinum Resistant ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718151420.793488671 ◽

2013 ◽

Author(s):

Brian Keith Bednarski

Keyword(s):

Rectal Cancer ◽

High Risk ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy

10.21236/ada566780 ◽

2012 ◽

Author(s):

Lee M. Krug

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Trial ◽

Peptide Vaccine ◽

Multimodality Therapy ◽

Pleural Mesothelioma ◽

Randomized Phase Ii ◽

Download Full-text

Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy

10.21236/ada592046 ◽

2013 ◽

Author(s):

Lee M. Krug

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Trial ◽

Peptide Vaccine ◽

Multimodality Therapy ◽

Pleural Mesothelioma ◽

Randomized Phase Ii ◽

Download Full-text

Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study)

PLoS ONE ◽

10.1371/journal.pone.0235381 ◽

2020 ◽

Vol 15 (6) ◽

pp. e0235381 ◽

Author(s):

Izabella Picinin Safe ◽

Marcus Vinícius Guimarães Lacerda ◽

Vitoria Silva Printes ◽

Adriana Ferreira Praia Marins ◽

Amanda Lia Rebelo Rabelo ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Hospitalized Patients ◽

Safety And Efficacy ◽

Randomized Phase Ii

Download Full-text